Low-osmolar contrast tagging in minimally cathartic CT colonography for colorectal cancer screening: an observational study
Abdominal Radiology · 2025
DOI: 10.1007/s00261-025-04971-3 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Abdominal Radiology, 2025. Verfasst von Anna Eligulashvili und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, The Bronx, USA. Hauptthemen laut MEDLINE: Colonography, Computed Tomographic, Contrast Media, Colorectal Neoplasms, Iohexol. Die Arbeit nennt 26 Literaturangaben. Gefördert von: GE Healthcare Ltd..
Abstract (Originalsprache)
OBJECTIVES: Adequate bowel preparation and tagging are critical in optimizing CTC performance. Iohexol has a higher safety profile than other available tagging agents. This study aims to determine if iohexol serves as an adequate fluid and stool tagging agent in conjunction with minimally cathartic bowel preparation. METHODS: In this prospective observational study, 50 participants ingested 50 mL of oral iohexol for tagging and 10 oz magnesium citrate for bowel preparation prior to CTC. Written informed consent was obtained. CTC was performed in all participants in at least two of the standard four positions (supine, prone, right decubitus, and left decubitus). Two board-certified abdominal radiologists independently scored the 6 colonic segments of participants who underwent successful CTC. The amount of residual fluid and solid stool, attenuation of tagged fluid, and efficacy of fluid and stool tagging were recorded in each segment. Statistical analyses were performed with R-4.4.0. RESULTS: 47 participants (mean age 66.39 ± 8.65 years; 39 female) underwent successful CTC. Of 1252 total colonic segments, 14.8% had no residual fluid and 59.5% had 3 pieces 6-9 mm or single pieces > 1 cm. CONCLUSION: Low-volume (50 mL) iohexol is an effective fluid and fecal tagging agent for CTC with a minimally cathartic bowel preparation. This provides an easy option to label residual material and cleanse the bowel for patients undergoing CTC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, The Bronx, USA.
- Department of Radiology, Albert Einstein College of Medicine, Montefiore Medical Center, The Bronx, USA. jyee@montefiore.org.
Förderung
- GE Healthcare Ltd.
Zitieren
APA
Eligulashvili, A., Ricci, Z., Kanmaniraja, D., Rezko, D., Ye, K. Q., & Yee, J. (2025). Low-osmolar contrast tagging in minimally cathartic CT colonography for colorectal cancer screening: an observational study. Abdominal Radiology. https://doi.org/10.1007/s00261-025-04971-3
Vancouver
Eligulashvili A, Ricci Z, Kanmaniraja D, Rezko D, Ye KQ, Yee J. Low-osmolar contrast tagging in minimally cathartic CT colonography for colorectal cancer screening: an observational study. Abdominal Radiology. 2025. doi:10.1007/s00261-025-04971-3
BibTeX
@article{Eligulashvili2025,
author = {Eligulashvili, Anna and Ricci, Zina and Kanmaniraja, Devaraju and Rezko, David and Ye, Kenny Q and Yee, Judy},
title = {Low-osmolar contrast tagging in minimally cathartic CT colonography for colorectal cancer screening: an observational study},
journal = {Abdominal Radiology},
year = {2025},
doi = {10.1007/s00261-025-04971-3}
}
EUVIMED